Literature DB >> 26610379

In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Erica B Sherry1, Phil Lee1,2, In-Young Choi3,4,5.   

Abstract

Metabolic disorders, whether hereditary or acquired, affect the brain, and abnormalities of the brain are related to cellular integrity; particularly in regard to neurons and astrocytes as well as interactions between them. Metabolic disturbances lead to alterations in cellular function as well as microscopic and macroscopic structural changes in the brain with diabetes, the most typical example of metabolic disorders, and a number of hereditary metabolic disorders. Alternatively, cellular dysfunction and degeneration of the brain lead to metabolic disturbances in hereditary neurological disorders with neurodegeneration. Nuclear magnetic resonance (NMR) techniques allow us to assess a range of pathophysiological changes of the brain in vivo. For example, magnetic resonance spectroscopy detects alterations in brain metabolism and energetics. Physiological magnetic resonance imaging (MRI) detects accompanying changes in cerebral blood flow related to neurovascular coupling. Diffusion and T1/T2-weighted MRI detect microscopic and macroscopic changes of the brain structure. This review summarizes current NMR findings of functional, physiological and biochemical alterations within a number of hereditary and acquired metabolic disorders in both animal models and humans. The global view of the impact of these metabolic disorders on the brain may be useful in identifying the unique and/or general patterns of abnormalities in the living brain related to the pathophysiology of the diseases, and identifying future fields of inquiry.

Entities:  

Keywords:  Brain; Inborn errors; MRI; MRS; Metabolic disorders

Mesh:

Year:  2015        PMID: 26610379     DOI: 10.1007/s11064-015-1772-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  429 in total

Review 1.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

2.  Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping.

Authors:  S G Kim
Journal:  Magn Reson Med       Date:  1995-09       Impact factor: 4.668

3.  Phenylketonuria in adulthood: a collaborative study.

Authors:  R Koch; B Burton; G Hoganson; R Peterson; W Rhead; B Rouse; R Scott; J Wolff; A M Stern; F Guttler; M Nelson; F de la Cruz; J Coldwell; R Erbe; M T Geraghty; C Shear; J Thomas; C Azen
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

4.  (1) H magnetic resonance spectroscopy of neurodegeneration in a mouse model of niemann-pick type C1 disease.

Authors:  John W Totenhagen; Eriko S Yoshimaru; Robert P Erickson; Theodore P Trouard
Journal:  J Magn Reson Imaging       Date:  2012-11-16       Impact factor: 4.813

5.  Alteration of interaction between astrocytes and neurons in different stages of diabetes: a nuclear magnetic resonance study using [1-(13)C]glucose and [2-(13)C]acetate.

Authors:  Na Wang; Liang-Cai Zhao; Yong-Quan Zheng; Min-Jian Dong; Yongchao Su; Wei-Jian Chen; Zi-Long Hu; Yun-Jun Yang; Hong-Chang Gao
Journal:  Mol Neurobiol       Date:  2014-07-22       Impact factor: 5.590

6.  Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome).

Authors:  James E Davison; Christian J Hendriksz; Yu Sun; Nigel P Davies; Paul Gissen; Andrew C Peet
Journal:  J Inherit Metab Dis       Date:  2010-10-01       Impact factor: 4.982

7.  Creatine transporter deficiency in two half-brothers.

Authors:  Orly Ardon; Cristina Amat di San Filippo; Gajja S Salomons; Nicola Longo
Journal:  Am J Med Genet A       Date:  2010-08       Impact factor: 2.802

8.  Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion.

Authors:  T Scarabino; T Popolizio; M Tosetti; D Montanaro; G M Giannatempo; R Terlizzi; S Pollice; A Maiorana; N Maggialetti; A Carriero; V Leuzzi; U Salvolini
Journal:  Radiol Med       Date:  2009-03-10       Impact factor: 3.469

9.  Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.

Authors:  S G Hasselbalch; G Oberg; S A Sørensen; A R Andersen; G Waldemar; J F Schmidt; K Fenger; O B Paulson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

10.  Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.

Authors:  Simon J A van den Bogaard; Eve M Dumas; Wouter M Teeuwisse; Hermien E Kan; Andrew Webb; Raymund A C Roos; Jeroen van der Grond
Journal:  J Neurol       Date:  2011-05-26       Impact factor: 4.849

View more
  4 in total

Review 1.  Imaging based magnetic resonance spectroscopy (MRS) localization for quantitative neurochemical analysis and cerebral metabolism studies.

Authors:  Phil Lee; Peter Adany; In-Young Choi
Journal:  Anal Biochem       Date:  2017-01-10       Impact factor: 3.365

2.  Oligodendrocytes Do Not Export NAA-Derived Aspartate In Vitro.

Authors:  Ana I Amaral; Mussie Ghezu Hadera; Mark Kotter; Ursula Sonnewald
Journal:  Neurochem Res       Date:  2016-07-09       Impact factor: 3.996

Review 3.  Altered brain metabolites in patients with diabetes mellitus and related complications - evidence from 1H MRS study.

Authors:  Xue Zhao; Qing Han; Xiaokun Gang; Guixia Wang
Journal:  Biosci Rep       Date:  2018-09-07       Impact factor: 3.840

4.  Monitoring Methylmalonic Aciduria by NMR Urinomics.

Authors:  Alina Nicolescu; Daniela Blanita; Chiril Boiciuc; Victoria Hlistun; Mihaela Cristea; Dorina Rotaru; Ludmila Pinzari; Ana Oglinda; Adela Stamati; Isabela Tarcomnicu; Andreea Tutulan-Cunita; Danae Stambouli; Sergiu Gladun; Ninel Revenco; Natalia Uşurelu; Calin Deleanu
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.